TrialMolecular oncology2017

Blood-based detection of RAS mutations to guide anti-EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue-based RAS testing.

Wolff Schmiegel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.